Marshall Wace’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-14,232
| Closed | -$1.23M | – | 2817 |
|
|
2024
Q4 | $1.23M | Buy |
14,232
+11,111
| +356% | +$959K | ﹤0.01% | 1524 |
|
|
2024
Q3 | $297K | Sell |
3,121
-2,251
| -42% | -$214K | ﹤0.01% | 1988 |
|
|
2024
Q2 | $491K | Buy |
+5,372
| New | +$491K | ﹤0.01% | 1785 |
|
|
2023
Q4 | – | Sell |
-7,776
| Closed | -$621K | – | 2194 |
|
|
2023
Q3 | $621K | Buy |
+7,776
| New | +$621K | ﹤0.01% | 1387 |
|
|
2023
Q1 | – | Sell |
-13,155
| Closed | -$1.02M | – | 2494 |
|
|
2022
Q4 | $1.02M | Buy |
13,155
+557
| +4% | +$43.3K | ﹤0.01% | 1593 |
|
|
2022
Q3 | $848K | Buy |
12,598
+7,330
| +139% | +$493K | ﹤0.01% | 1852 |
|
|
2022
Q2 | $404K | Buy |
5,268
+628
| +14% | +$48.2K | ﹤0.01% | 2228 |
|
|
2022
Q1 | $370K | Buy |
+4,640
| New | +$370K | ﹤0.01% | 2213 |
|